Pediatrix Medical (MD) Depreciation & Amortization (CF) (2009 - 2026)

Pediatrix Medical has disclosed Depreciation & Amortization (CF) across 18 years of filings, most recently posting $6.1 million for Q1 2026.

• In Q1 2026, Depreciation & Amortization (CF) rose 14.76% year-over-year to $6.1 million; the TTM figure through Mar 2026 stood at $22.6 million (down 17.01% YoY), while the FY2025 annual figure was $21.8 million, down 32.27% from the prior year.
• Depreciation & Amortization (CF) grew to $6.1 million in Q1 2026, from $5.6 million in the prior quarter.
• Over the last five years, Depreciation & Amortization (CF) for MD reached as high as $10.3 million in Q1 2024 and fell as low as $5.3 million in Q2 2025.
• The 5-year median for Depreciation & Amortization (CF) is $8.8 million (2022), against an average of $7.8 million.
• Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) climbed 16.25% — and 2025, when it slumped 48.27%.
• A 5-year view of Depreciation & Amortization (CF) shows it stood at $9.1 million in 2022, then declined by 0.81% to $9.1 million in 2023, then retreated by 24.16% to $6.9 million in 2024, then dropped by 18.07% to $5.6 million in 2025, then gained by 8.67% to $6.1 million in 2026.
• According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $6.1 million, $5.6 million, and $5.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.